Europe ECG Telemetry Device Market

Market Introduction

ECG device monitors and record electrical activity of the heart and the device detects and picks up electrical impulses generated by the polarization and depolarization of cardiac tissue and translate them into waveform. This helps physician or cardiologist to diagnose cardiac abnormalities as well as size and position of chambers.

Thus, a surge in geriatric population is expected to create a significant demand for ECG telemetry device in the coming years, which is further anticipated to drive the ECG telemetry device market.

The current coronavirus (COVID-19) outbreak has been declared by WHO as a public health emergency of international concern according to the International Health Regulation. Also, the pandemic has halted the adoption of new medical device policy and delayed clinical trials and disrupted processes. Two consecutive waves of coronavirus had devastating impact on economic activities in the Europe. Implementation of social distancing and lockdown policies led to closing of cardiac centers and patient visits for elective heart treatments. This factor negatively impacted the adoption of ECG telemetry devices in the region. The European Commission recently postponed the application date of the MDR for one-year due to COVID-19 pandemic. The Medical Device Regulation (MDR) requires manufacturers to conduct Post Market Clinical Follow-Up (PMCF) studies to demonstrate the continued safety and performance of their devices. This is expected to impact the new product launches and ongoing clinical trials of medical devices, impacting sales and growth of the Europe ECG telemetry devices market. In addition, disrupted supply chains, extended lockdowns, and cancelling of travel visits of sales personnel of companies have also negativity affected the growth of the ECG telemetry devices market.

Europe ECG Telemetry Device Strategic Insights

Strategic insights for the Europe ECG Telemetry Device provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe ECG Telemetry Device Report Scope

Europe ECG Telemetry Device Regional Insights

The geographic scope of the Europe ECG Telemetry Device refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The ECG telemetry device market in Europe is expected to grow from US$ 561.1 million in 2021 to US$ 962.9 million by 2028; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028. The consolidation of the ECG telemetry devices industry through the expansion and upgrading of product lines is an emerging trend followed by prime telemedicine companies. With the increasing patient population and rising awareness toward technologies, the companies are striving to expand their manufacturing capabilities. This factor has led to geographic diversification, enormous capital generation, therapeutic and development expertise building, and steady technical resource availability among the industry giants, which helps them meet the requirement of healthcare facilities and patients suffering from CVDs such as heart valve complications, abnormal heart rhythms, or arrhythmias.

Key Market Segments

In terms of product, the resting ECG devices segment accounted for the largest share of the Europe ECG telemetry device market in 2020. In terms of end user, the hospitals segment held a larger market share of the ECG telemetry device market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the ECG telemetry device market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Cardiac Science Corporation

,

,

,

,

,

,

,

Reasons to buy report

• To understand the Europe ECG telemetry device market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe ECG telemetry device market
• Efficiently plan M&A and partnership deals in Europe ECG telemetry device market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe ECG telemetry device market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

EUROPE ECG TELEMETRY DEVICE MARKET SEGMENTATION

By Product

• Resting ECG Devices
• Stress ECG Devices
• Others

By End User

• Home Healthcare
• Hospitals

By Country

• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Companies Mentioned

1. Cardiac Science Corporation
2. GE Healthcare Inc.
3. Medtronic Inc.
4. Mindray Medical International Ltd.
5. Nihon Kohden Corporation
6. Philips Healthcare
7. Dragger
8. Welch Allyn Inc